You are here: Industry Insights > Fujifilm

News List

Fujifilm Boosts Production of Avigan Tablet for COVID-19 contractpharma
April 16, 2020
Expands manufacturing capacity at Fujifilm Toyama Chemical to increase production of its influenza antiviral drug.
Influenza antiviral Avigan® (favipiravir) to enter Phase III trials in COVID-19 patients europeanpharmaceuticalreview
April 06, 2020
The developers of Avigan have increased production and announced a Phase III clinical trial testing its efficacy against COVID-19.
FUJIFILM Irvine Scientific Leverages Discovery Research Biz contractpharma
April 03, 2020
Aims to enable faster, efficient delivery of Cellular Dynamics iPSC-derived products for drug discovery and development.
Fujifilm Creates Discovery Research Organization contractpharma
April 02, 2020
Will provide Fujifilm Cellular Dynamics' iPSC-derived products through their worldwide distribution channels.
Fujifilm Invests $83M to Expand Microbial Capacity contractpharma
March 23, 2020
Fujifilm Corporation has unveiled plans to invest approximately $83 million to expand the microbial production capacity of Fujifilm Diosynth Biotechnologies (FDB).
Chinese official says Fujifilm’s Favipiravir could treat Covid-19 pharmaceutical-technology
March 19, 2020
China’s Science and Technology Ministry official Zhang Xinmin has said that Japan-based Fujifilm’s anti-flu drug Favipiravir helped Covid-19 patients recover.
FUJIFILM Diosynth Appoints Head of NC Ops contractpharma
March 18, 2020
Christine Vannais brings more than 20 years of experience and will serve as chief operating officer.
FUJIFILM Cellular Dynamics Opens iPSC Facility contractpharma
March 03, 2020
New Innovation Facility for Advanced Cell Therapy (i-FACT) will house development and manufacture of iPSCs for therapeutic applications.
FUJIFILM Diosynth Expands Gene Therapy Mfg. Capacity contractpharma
March 03, 2020
The $35 million capacity expansion at College Station, TX will add cell culture and high throughput manufacturing suites.
Fujifilm Establishes U.S. Bio Center ContractPharma
December 11, 2019
To start full-scale translational research for biotherapeutics in the U.S.

Previous page 1 2 3 4 5 Next page